Skip to main content
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRS ISIN · US00461U1051 LEI · 5493000B2LQ9QTW1DF52 US Manufacturing
Filings indexed 843 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US ACRS

About Aclaris Therapeutics, Inc.

https://www.aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Recent filings

Filing Released Lang Actions
10-Q - Aclaris Therapeutics, Inc. (0001557746) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Aclaris Therapeutics, Inc. (0001557746) (Filer)
Regulatory Filings
2026-05-07 English
8-K - Aclaris Therapeutics, Inc. (0001557746) (Filer)
Regulatory Filings
2026-04-28 English
ARS - Aclaris Therapeutics, Inc. (0001557746) (Filer)
Annual Report
2026-04-23 English
DEF 14A - Aclaris Therapeutics, Inc. (0001557746) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English
SCHEDULE 13G/A - Aclaris Therapeutics, Inc. (0001557746) (Subject)
Major Shareholding Notification
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.